Dr. Thomas Nabhani M.D., PH.D

Recommended Articles

• Three-Week Chemotherapy Dosing Reconfirmed as First-Line Treatment of Ovarian Cancer

  Chemotherapy as a treatment option for cancer has existed for decades, and has long been the standard of care and first line of treatment for almost all forms of cancer. The term is an umbrella term referring to the use of medicines to halt the growth of cancerous tumors and to kill off cancerous...

• The Most Common Misconceptions About Breast Cancer

  There is so much information you can read online about breast cancer. Some information may be acquired in the community, friends, or family that is totally misleading or incorrect. Although not backed up with solid evidence, such information can cause a lot of media attention, which can further...

• What Is an X-Ray?

  An X-ray is a type of electromagnetic radiation, which can be used to take digital images of parts of the human body. It is the same with visible light but has a certain different characteristic. The beneficial use of an X-ray is for medical imaging. It can help the physician to look inside your...

• What Procedures Are Used to Treat Bladder Cancer?

  There are various treatment options for bladder cancer. Each option has its own procedure on how it is carried out. The type of treatment is also chosen based on several factors such as:...

• Alternative Treatment for Prostate Cancer

  Prostate cancer has become a common disease in men, especially those aged from 50 years and above. Having prostate cancer comes with its own effects that no one wants to be part of. Various symptoms accompany an affected prostate gland. Such symptoms may include pain when urinating, high frequency...

• Radiation Therapy vs Chemotherapy

  Radiation TherapyIn this method, the doctors will use gamma rays, x-rays, and charged particles that will be directed at, implanted, or introduced directly into the blood stream. In this form of treatment, you will find the three types of therapy that will all be described according to way they...